Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TRST
|
Kevin M Curley
EXECUTIVE VICE PRESIDENT & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 450 Reduced 1.21% |
$16,546
$36.77 p/Share
|
Nov 21
2024 |
|
FSFG
|
Kent L. Parisien
EVP, Area President |
SELL
Payment of exercise price or tax liability
|
Direct | 241 Reduced 4.14% |
$6,989
$29.0 p/Share
|
Nov 21
2024 |
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 8,760 Added 0.0% |
$105,558
$12.05 p/Share
|
Nov 21
2024 |
|
FSFG
|
James E. Valete
EVP, Chief SBA Lending Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 144 Reduced 5.93% |
$4,176
$29.0 p/Share
|
Nov 21
2024 |
|
FSFG
|
James E. Valete
EVP, Chief SBA Lending Officer |
BUY
Grant, award, or other acquisition
|
Direct | 320 Added 10.94% |
-
|
Nov 21
2024 |
|
FSFG
|
Anthony A Schoen
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 575 Reduced 0.59% |
$16,675
$29.0 p/Share
|
Nov 21
2024 |
|
FSFG
|
Anthony A Schoen
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 320 Added 0.33% |
-
|
Nov 21
2024 |
|
FSFG
|
James W Nelson
EVP and Chief Risk Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 293 Reduced 4.87% |
$8,497
$29.0 p/Share
|
Nov 21
2024 |
|
FSFG
|
James W Nelson
EVP and Chief Risk Officer |
BUY
Grant, award, or other acquisition
|
Direct | 320 Added 5.03% |
-
|
Nov 21
2024 |
|
MAV
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 13,379 Added 0.0% |
$115,594
$8.64 p/Share
|
Nov 21
2024 |
|
FLL
|
Lewis A. Fanger
Sr. VP, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 37,738 Reduced 12.91% |
$190,576
$5.05 p/Share
|
Nov 21
2024 |
|
FLL
|
Lewis A. Fanger
Sr. VP, CFO and Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct | 37,738 Added 11.43% |
$51,701
$1.37 p/Share
|
Nov 21
2024 |
|
FSFG
|
James D. Nef
SVP, Dir of Acctg |
SELL
Payment of exercise price or tax liability
|
Direct | 69 Reduced 6.9% |
$2,001
$29.0 p/Share
|
Nov 21
2024 |
|
MEG
|
J Thomas Presby |
BUY
Grant, award, or other acquisition
|
Indirect | 5,000 Added 0.0% |
$98,850
$19.77 p/Share
|
Nov 21
2024 |
|
MHI
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 30,062 Added 0.0% |
$282,883
$9.41 p/Share
|
Nov 21
2024 |
|
SMFR
|
Kevin Feeley
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 12,019 Reduced 26.74% |
$869,454
$72.34 p/Share
|
Nov 21
2024 |
|
AFRM
|
Robert O'Hare
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 29,840 Added 50.0% |
$1,247,312
$41.8 p/Share
|
Nov 21
2024 |
|
AFRM
|
Robert O'Hare
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 29,840 Reduced 100.0% |
$1,939,898
$65.01 p/Share
|
Nov 21
2024 |
|
CFLT
|
Matthew Craig Miller
Director |
BUY
Conversion of derivative security
|
Indirect | 458,865 Added 0.0% |
-
|
Nov 21
2024 |
|
CFLT
|
Matthew Craig Miller
Director |
SELL
Open market or private sale
|
Indirect | 541,850 Reduced 0.0% |
$16,439,729
$30.34 p/Share
|
Nov 21
2024 |
|
BLKB
|
Anthony W Boor
CFO & Exec VP of Fin. & Admin. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 6.66% |
$846,500
$84.65 p/Share
|
Nov 21
2024 |
|
BLKB
|
Michael P Gianoni
President and CEO |
SELL
Open market or private sale
|
Direct | 2,100 Reduced 0.56% |
$180,600
$86.0 p/Share
|
Nov 21
2024 |
|
VTOL
|
Solus Alternative Asset Management LP
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,255 Reduced 0.0% |
$161,775
$38.02 p/Share
|
Nov 21
2024 |
|
MXL
|
Ted L Tewksbury Iii
Director |
SELL
Open market or private sale
|
Direct | 5,800 Reduced 7.68% |
$89,088
$15.36 p/Share
|
Nov 21
2024 |
|
TRST
|
Robert J Mccormick
CHAIRMAN, PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,117 Reduced 0.74% |
$77,842
$36.77 p/Share
|
Nov 21
2024 |
|
TRST
|
Robert J Mccormick
CHAIRMAN, PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 4,184 Added 1.44% |
-
|
Nov 21
2024 |
|
CVS
|
Guy P Sansone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 20.83% |
$125,620
$57.1 p/Share
|
Nov 21
2024 |
|
CVS
|
Douglas H. Shulman
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 50.0% |
$125,620
$57.1 p/Share
|
Nov 21
2024 |
|
TRST
|
Eric W Schreck
EVP & TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct | 1,107 Added 3.72% |
-
|
Nov 21
2024 |
|
TRST
|
Eric W Schreck
EVP & TREASURER |
SELL
Payment of exercise price or tax liability
|
Direct | 395 Reduced 1.38% |
$14,524
$36.77 p/Share
|
Nov 21
2024 |
|
ALAB
|
Jitendra Mohan
Chief Executive Officer |
SELL
Open market or private sale
|
Indirect | 171,064 Reduced 0.0% |
$17,710,255
$103.53 p/Share
|
Nov 21
2024 |
|
CVS
|
Leslie V Norwalk
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 50.0% |
$125,620
$57.1 p/Share
|
Nov 21
2024 |
|
FSFG
|
Pamela Bennett Martin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 0.98% |
-
|
Nov 21
2024 |
|
TRST
|
Michael M Ozimek
EXECUTIVE VICE PRESIDENT & CFO |
BUY
Exercise of conversion of derivative security
|
Direct | 1,107 Added 3.67% |
-
|
Nov 21
2024 |
|
TRST
|
Michael M Ozimek
EXECUTIVE VICE PRESIDENT & CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 426 Reduced 1.47% |
$15,664
$36.77 p/Share
|
Nov 21
2024 |
|
FSFG
|
Douglas A York
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 0.39% |
-
|
Nov 21
2024 |
|
FSFG
|
Martin Padgett
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 2.54% |
-
|
Nov 21
2024 |
|
PCOR
|
Iconiq Strategic Partners Ii, L.P. |
SELL
Other acquisition or disposition
|
Direct | 766,624 Reduced 36.42% |
-
|
Nov 21
2024 |
|
PCOR
|
Iconiq Strategic Partners Ii, L.P. |
SELL
Other acquisition or disposition
|
Indirect | 884,284 Reduced 0.0% |
-
|
Nov 21
2024 |
|
FSFG
|
John E Colin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 2.49% |
-
|
Nov 21
2024 |
|
CVS
|
Jean Pierre Millon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,200 Added 32.77% |
$125,620
$57.1 p/Share
|
Nov 21
2024 |
|
FSFG
|
Frank Czeschin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 1.17% |
-
|
Nov 21
2024 |
|
FSFG
|
John P Lawson Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 0.69% |
-
|
Nov 21
2024 |
|
CVS
|
Nancy Ann Deparle
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,331 Added 6.39% |
$133,100
$57.1 p/Share
|
Nov 21
2024 |
|
FSFG
|
L. Chris Fordyce
Director |
BUY
Grant, award, or other acquisition
|
Direct | 250 Added 0.6% |
-
|
Nov 21
2024 |
|
TRST
|
Anthony J Md Phd Marinello |
BUY
Exercise of conversion of derivative security
|
Direct | 739 Added 2.97% |
-
|
Nov 21
2024 |
|
TRST
|
Anthony J Md Phd Marinello |
SELL
Sale (or disposition) back to the issuer
|
Direct | 739 Reduced 3.07% |
$27,173
$36.77 p/Share
|
Nov 21
2024 |
|
PCOR
|
William J.G. Griffith |
SELL
Other acquisition or disposition
|
Indirect | 1,650,908 Reduced 0.0% |
-
|
Nov 21
2024 |
|
CVS
|
J Scott Kirby
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,933 Added 25.51% |
$167,474
$57.1 p/Share
|
Nov 21
2024 |
|
MTB
|
John P Barnes
Director |
SELL
Open market or private sale
|
Indirect | 20,000 Reduced 0.0% |
$4,336,000
$216.8 p/Share
|
Nov 21
2024 |